Last reviewed · How we verify
NCT07014657
Effect of Digital Combined Decongestive Therapy in Patients With Breast Cancer-related Lymphedema: a Follow-up Study
NA trial testing Digital Combined Decongestive Therapy in Breast Cancer-Related Lymphedema in 29 participants. Completed in 20 June 2024.
5 January 2024
Quick facts
| Lead sponsor | Bezmialem Vakif University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 29 |
| Start date | 10 January 2018 |
| Primary completion | 5 January 2024 |
| Estimated completion | 20 June 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Digital Combined Decongestive Therapy
Conditions studied
- Breast Cancer-Related Lymphedema — all drugs for Breast Cancer-Related Lymphedema →
Sponsor
Bezmialem Vakif University
Who can join
Eligibility, female only, with Breast Cancer-Related Lymphedema. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study investigated the short- and long-term effects of digital combined decongestive therapy in breast cancer-related lymphedema. Limb volume and quality of life (Lymph-ICF) were assessed at baseline, post-treatment, and 12-week follow-up.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07014657
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Digital Combined Decongestive Therapy
Trials testing the same drug.
- NCT07014566 — Effectiveness of Digital Physiotherapy in the Short and Long-Term Management of Lower Extremity Lymphedema · NA · completed
Other recruiting trials for Breast Cancer-Related Lymphedema
Currently open trials in the same condition.
- NCT07154043 — Comparison of IPC Therapy as an Alternative or an Adjunct to MLD Within CDT for BCRL · NA · recruiting
Other Bezmialem Vakif University trials
Trials by the same sponsor.
- NCT07369297 — PULP SENSIBILITY AND MASSETER INHIBITORY REFLEX IN DIABETIC POLYNEUROPATHY · not yet recruiting
- NCT07433595 — Association Between Child and Parental Stress and Bruxism in Children Aged 8-11 Years · not yet recruiting
- NCT07443111 — Comparison of Virtual Reality-Based and Routine Preoperative Education on Surgical Anxiety and Salivary Cortisol · NA · not yet recruiting
- NCT07421349 — Comparison of Pulmonary Functions and Respiratory Muscle Strength Between Children With Hearing Impairment and Healthy P · not yet recruiting
- NCT07414615 — Aerobic Training in Lower Extremity Lymphedema · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07014657 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bezmialem Vakif University
- Last refreshed: 11 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07014657.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing